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Background: Cross-sectional imaging techniques as magnetic resonance enterography (MRE) may offer additional
information on transmural inflammation, stricturing and fistulising complications in Crohn’s disease (CD). The purpose of our
study was to evaluate the diagnostic accuracy of Magnetic Resonance Imaging (MRI) combined with Diffusion-weighted
Imaging (DWI) and MRE for determination of inflammation in small bowel CD.
Methods: MR imaging examination was performed with a GE Signa EXCITE 3.0 T MRI scanner. The optimal b value in
DWI with a learning cohort of patients was determined. The diagnostic accuracy for active lesions and disease activity
were accessed by MRE combined with DWI.
Results: The b value 800 s/mm2 group showed the highest diagnostic sensitivity (74.19%) for diagnostic assessment of
active Crohn’s lesions on DWI. MRE combined with DWI showed the highest sensitivity (93.55%), specificity (89.47%)
and diagnostic accuracy (92%) compared with MRE or DWI alone. The segmental MR score (MR-score-S) showed a
significantly positive correlation with the Capsule Endoscopy Crohn’s Disease Activity Index Score (CECDAI-S) (r = 0.717,
p < 0.01). The total MR score (MR-score-T) showed significant association with C-reactive protein (CRP) (r = 0.445,
p = 0.019) and erythrocyte sedimentation rate (ESR) (r = 0.688, p < 0.01).
Conclusions: MRE combined with DWI improves the diagnostic accuracy for active lesions and correlates the
endoscopic disease activity. MRE with DWI could represent a non-invasive tool in assessing active inflammation
in CD.Background
Crohn’s disease (CD) is characterized by chronic inflam-
mation with a relapsing and remitting natural history.
Treatment is generally effective in relieving clinical
symptoms. However, preliminary evidence has suggested
that therapeutic strategy for endoscopic remission might
be associated with better outcome [1]. Mucosal healing
(MH) or deep remission emerges as the therapeutic end-
point in patients with CD, especially in severe or compli-
cated cases. Therefore, monitoring the disease with
endoscopy and cross-sectional imaging is proposed to
assess MH. Endoscopy allows direct visualization of the
mucosa and acquisition of biopsies. In CD, although* Correspondence: billzhu49@hotmail.com; xujianrong@renji.com
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unless otherwise stated.endoscopy is an invasive procedure and expensive in
some countries, it is nearly the ‘golden’ standard for dis-
ease activity monitoring of luminal lesions. To determine
the severity and therapeutic responses based on normal-
ized, endoscopic manifestation, a variety of disease activ-
ity indices have been developed over decades [2,3]. For
small bowel CD, the advent of capsule endoscopy has
improved our understanding of the lining of the small
bowel. Extensive consensus has established that capsule
endoscopy visualize the whole small bowel, and it help
to assess the small-bowel severity in CD [4]. However,
capsule endoscopy also shows some limitations. The
focal length of the vision is too short to measure the size
of lesions reliably. However capsule endoscopy is not
possible in stricturing disease, hence radiological imaging
is usually required.
Cross-sectional imaging techniques as computed
tomography enterography (CTE) and MRE may offeris an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of all patients
Mean ± deviation Range (min, max)
Age (year) 27 ± 10 13, 63
Course of disease (month) 34 ± 30 1, 122
Leucocyte (10^9/L) 7.17 ± 2.66 2.72, 16.11
Erythrocyte (10^9/L) 4.32 ± 0.68 2.67, 5.58
Hemoglobin (g/L) 112.38 ± 20.67 60, 150
Platelet (10^9/L) 304.47 ± 97.02 103, 582
High sensitive CRP (mg/L) 22.20 ± 23.16 0.7, 98
Blood sedimentation (mm/h) 27.26 ± 19.22 1, 80
Albumin (g/L) 35.0 ± 5.20 26.2, 45.5
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stricturing and fistulising complications [5]. CTE delin-
eate the extent and severity of bowel wall inflammation,
apart from detecting extra-luminal findings [6]. How-
ever, the increased spatial resolution of CT with new
multidetectors carries along with the greater dose of
ionizing radiation. In fact, effective dose of radiation for
CTE is nearly five times higher than small bowel follow
through [7]. MRE is preferred for the evaluation of the
gastrointestinal tract because of the absence of ionizing
radiation, along with the similar sensitivity and diagnos-
tic accuracy of luminal and extraluminal lesions [8,9].
Most of the recent researches focused on the inflammatory
activity of involved segments using gadolinium-enhanced
T1-weighted sequence for evaluation of CD. MRE signs of
inflammatory activity in the bowel segments showed a good
correlation with the presence and severity of endoscopic
lesions [10,11]. MRE can measure intestinal thickness,
enhancement after contrast injection, edema and ulceration
or even more sophisticated measure as diffusion weighted
imaging (DWI). DWI derives its image contrast from differ-
ences in the motion of water molecules between tissues
[12]. DWI has been reported for colonic lesions in active
CD, which could avoid the use of gadolinium injection [13].
Thus, the absence of gadolinium-induced nephrogenic
systemic fibrosis indicates that DWI might be the proper
method for long time follow-up in CD.
To quantify MRI assessment in each segment, Magnetic
Resonance Index of Activity (MaRIA) is used and gets the
satisfactory consistency with Crohn’s Disease Endoscopic
Index of Severity (CDEIS). However, only few studies were
found to evaluate small bowel inflammation using DWI to
date. Therefore, the purpose of our study was to evalu-
ate the diagnostic accuracy of MRI combined with DWI




From September 2010 to September 2012, a total of
thirty-six consecutive active CD patients were included
in our restrospective study, including nineteen males
and seventeen females (Table 1). All patients underwent
both MR examination and single/double balloon entero-
scopy within the same week. All patients gave written
informed consent to participate in the present study.
The ethic approval was provided by the Institutional
Review Board (IRB) of the Ren Ji Hospital, School of
Medicine, Shanghai Jiao Tong University.
The criteria of enrollment included: Harvey-Bradshaw
Crohn’s Disease Activity Index > 4; C-reactive protein
(CRP) > 8 mg/L or erythrocyte sedimentation rate (ESR) >
20 mm/h; Ulcers in at least one segment of bowels. The
criteria of exclusion were intolerance or contraindication toundergo single/double balloon enteroscopy or MRE; Preg-
nancy; Active infection.MRE protocol
MR imaging examination was performed with a GE Signa
EXCITE 3.0 T MRI scanner (GE HealthCare, Milwaukee,
WI, USA). Patients fasted for over 8 hours before exami-
nations and took 2000 ml solution of Polyethylene Glycol
Electrolyte (PGE) powder (Wanhe Inc., Shenzhen, China)
for bowel preparation. Forty five minutes before scanning,
additional 1000 ml PGE solution was administered orally
to each patient for small bowel distention. Scopolamine
10 mg (Shanghai Xinyi Pharmaceuticals Co., Ltd., Shanghai,
China) was administered intramuscularly 10 minutes before
the examination.
After acquiring standard three-plane scout images
with supine position, sequences were obtained from the
abdomen and pelvis using an eight-channel, phased-
array body coil. All sequences except T1W imaging
were scanned with respiratory-triggering method. T2-
weighted single shot fast spin-echo images (ssFSE) were
acquired in axial and coronal plane. The scan parame-
ters were as follows: TR/TE, 2000-3400/68 msec; slice
thickness, 5 mm; interslice gap, 0 mm; matrix, 384*192;
FOV, 42*25 cm; NEX, 0.6; SENSE factor, 2. Axial T1-
weighted three-dimensional fast spoiled gradient echo
(FSPGR) was acquired with breath-holding technique:
TR/TE, 310/2.5 msec; slice thickness, 6 mm; interslice
gap, 0 mm; matrix, 288*192; FOV, 35*25 cm; NEX, 0.5;
SENSE factor, 2.
Scan parameters of DWI were as follows: TR/TE, 5820-
6200/74-78 msec; slice thickness, 6 mm; interslice gap,
2 mm; matrix, 128*96; FOV, 40*28 cm; NEX, 4. The fre-
quency direction was left to right. Diffusion-encoding gra-
dients were applied as 5 b values from 0 to 2500 s/mm2
(0, 800, 1500, 2000 and 2500 s/mm2) along the three
orthogonal directions of motion-probing gradients. The
apparent diffusion coefficient (ADC) maps were auto-
matically constructed on a pixel-by-pixel basis.
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ducted before and after intravenous administration of
Magnevist (0.1 ml/kg; Bayer Vital Gmbh, Germany) at a
rate of 3 ml/s for dynamic study in coronal plane (arter-
ial phase 30 s, portal phase 70 s and post-equilibrium
phase 90 s after injection). TR/TE, 3.3/1.5 msec; slice
thickness, 2.4 mm; interslice gap, −1.8 mm; matrix,
256*288; FOV, 40*40 cm; NEX, 0.7.
The acquisition time of the entire examination for
each patient was approximately 30 minutes.
MRI evaluation
Determine the optimal b value in DWI with a learning
cohort of patients
Qualitative analysis The manifestation of intestinal
anatomic structure on DWI was evaluated on a three-
point scale as follows: 0 = both inflammatory and normal
intestinal wall structure was clear, 1 = inflammatory in-
testinal wall structure was clear while partial normal in-
testinal wall structure was vague, 2 = only partial positive
or negative intestinal wall structure could be identified.
The diagnostic efficacy of inflammatory lesions on DW
images would be evaluated and compared with the re-
sults of enteroscopy.
Quantitative analysis The signal-to-noise ratio (SNR)
and contrast-to-noise ratio (CNR) in all four different b
value groups would be measured. Image noise was mea-
sured from a large area (approximately 260 cm2) outside
the abdomen parenchyma and defined as the standard
deviation of background signal intensity. The signal
contrast and ADCs would be measured on both normal
and inflammatory bowel wall when these images were
properly magnified, and ROI areas would be determined
as maximum. On DW images, ROIs were placed on the
segments where the signal was the most significant.
MRE combined with DWI improves the diagnostic
accuracy for active lesions
Three different protocols were adopted for image evalu-
ation in this session. Protocol A: only DW imaging was
used; protocol B: only (MRE) imaging was used, includ-
ing T1WI, T2WI, and LAVA; protocol C: both DW im-
aging and MRE imaging were used. In protocol A, the
intestinal segment would be evaluated as positive when
it demonstrated significant high signal intensity on DWI
and low signal intensity on ADC map. In protocol B, the
segments would be evaluated as positive then it demon-
strated high signal intensity on T2WI, wall thickening
more than 3 mm and apparent enhancement in LAVA
imaging. In protocol C, the segments would be evaluated
as positive when it appeared abnormal on both DW and
MRE imaging. The b value adopted here would depend
on the outcome we gained in the part of “Determine theoptimal b value in DWI with a learning cohort of
patients”. The diagnostic effect of these three reading pro-
tocols would be compared with the results of enteroscopy.
MRE combined with DWI correlates the endoscopic
disease activity
Image evaluation was performed on the GE workstation
(GE Healthcare, AW4.2). All images were evaluated by
two experienced gastrointestinal radiologists (4 and
6 years of experience) who were blinded to clinical
symptoms and results of enteroscopy. For any discrepan-
cies in the data analysis, a joint reading session was per-
formed to obtain consensus. In DW images, the intestinal
segment would be evaluated as positive when it demon-
strated significant high signal intensity on DWI and low
signal intensity on ADC map. The b value adopted here
would depend on the outcome we gained in the part of
“Determine the optimal b value in DWI with a learning
cohort of patients”. The small intestinal segments were
defined with coronal T2WI sequence: duodenum, jejunum
(left upper abdomen), proximal ileum (middle and left
lower abdomen), distal ileum (right lower abdomen and
pelvis) and terminal ileum (10 cm up to ileal valve). Based
on a comprehensive review of the literature, eight radio-
logical signs were studied: (1) DWI hyper-intensity, (2)
layer differentiation of DWI hyper-intensity, (3) bowel
wall enhancement after intravenous contrast medium
administration, (4) differentiation between the mucosae-
submucosa complex and the muscularis propria, (5) bowel
wall thickening, (6) mesenteric edema, (7) the presence of
ulcers, and (8) the presence of polypoid hyperplasia. Fur-
thermore, the presence or absence of a radiological sign in
a given segment was rated ‘1’ or ‘0’, respectively. A modi-
fied MR scoring system was adopted: The segmental MR
score (MR-score-S) was calculated as the sum of the
numerical values obtained for the eight radiological signs
for a given segment. The total MR-score (MR-score-T)
was calculated as the sum of the MR-score-S in individual
patient.
Endoscopic evaluation
The interval between MR examination and single/double
balloon enteroscopy (SBE/DBE) was less than one weeks.
Mean oral intubation depth was about 250 cm and Mean
anal intubation depth was about 129 cm respectively.
Biopsy specimens were taken from suspected lesions.
Endoscopic images were evaluated by two experienced
gastroenterologists. Due to the lack of scoring system for
enteroscopy, the severity and extent of lesions in small
bowel were assessed by the Capsule Endoscopy Crohn’s
Disease Activity Index (CECDAI) [14]. For individual pa-
tient, five intestinal segments were defined: duodenum,
jejunum, proximal ileum, distal ileum and terminal ileum.
The segmental CECDAI score (CECDAI-S) was calculated
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(CECDAI-T) was defined as the sum of the CECDAI
score in a patient.
Statistical analysis
Statistical analysis was performed using SPSS 11.5.
Quantitative variables are represented as the mean ±
standard deviation, and discrete variables were repre-
sented as frequencies or percentages. The evaluation of
CNR, SNR and ADCs weere performed using one-way
ANOVA. The diagnostic accuracy was performed using
Chi-Square comparison. The correlations between MR
scores and endoscopic scores, as well as clinical and bio-
logical markers of disease activity were calculated by
Spearmen rank correlation test.
Results
Characteristics of included subjects
In current study, a total of 100 intestinal segments were
evaluated (36 terminal ileum segments, 33 distal ileum
segments, 25 proximal ileum segments, 5 jejunal seg-
ments and 1 duodenal segment), which included 62
positive segments and 38 negative segments. Sixteen pa-
tients were diagnosed with complication: 3 cases of internal
fistula, 5 cases of abdominal abscess, 4 cases of anal fistula
and 4 cases of anal abscess.
Determine the optimal b value in DWI with a learning
cohort of patients
SNR and CNR decreased remarkably when b value 2000 s/
mm2 and 2500 s/mm2 was adopted. There was significant
differences existed in SNR (F= 17.074, p < 0.01) and CNR
(F= 14.920, p < 0.01) when b value as 800 s/mm2 and
1500 s/mm2, respectively. The ADCs of the inflammatory
intestinal segments were significantly lower compared
with those in the normal segments using all four b values
(p < 0.01) (Figure 1). It was indicated that no matter what
b value was chosen, the ADC difference between inflam-
matory and normal bowel segments was significant, and it
was hard to tell which b value was better.
Considering the optimal image quality of DWI, the b
value 800 s/mm2 was adopted as scale 0. When b value
1500 s/mm2 was selected, 7 cases were evaluated as scale
1 and 29 cases as scale 0. When b value 2000 s/mm2
was selected, 11 cases were evaluated as scale 1 and the
other 25 cases were evaluated as scale 2. When b value
2500 s/mm2 was selected, all cases were evaluated as
scale 2 (Figure 2).
The b value 800 s/mm2 group showed the highest
diagnostic sensitivity (74.19%) for diagnostic assessment
of active Crohn’s lesions on DWI. However, the specifi-
city was quite low in b value 800 s/mm2 group (39.47%).
Among four different b groups, the diagnostic accuracy
was similar (all p > 0.05) (Figure 3).MRE combined with DWI improves the diagnostic
accuracy for active lesions
The diagnostic accuracy of inflammatory segments using
three reading protocols was also assessed. MRE combined
with DWI showed the highest sensitivity (93.55%), specifi-
city (89.47%) and diagnostic accuracy (92%) compared
with MRE or DWI alone (Table 2). The combination of
MRE and DWI could improve diagnostic sensitivity and
specificity (Figures 4 and 5).
MRE combined with DWI correlates the endoscopic
disease activity
In segmental analysis, MR-score-S showed a significantly
positive correlation with CECDAI-S (r = 0.717, p < 0.01).
Similarly, MR-score-T was found to be significantly cor-
related with CECDAI-T (r = 0.535, p < 0.01) in individual
patient (Figure 6).
Moreover, to determine the specific signs predicting
clinical and endoscopic disease activity, Receiver Operator
Curves (ROC) were used. The Area Under the Receiver
Operator Curve (AUROC) indicated that bowel wall en-
hancement was the optimal predictor of inflammation
(AUROC=0.87) with the satisfactory sensitivity (79.4%) and
specificity (94.3%). Besides, DWI hyper-intensity (AUROC=
0.83) and bowel wall thickening (AUROC=0.80) could also
predict active inflammation pretty well. Interestingly, It was
demonstrated that the layer differentiation of DWI hyper-
intensity and differentiation between the mucosaesubmucosa
complex and the muscularis propria presented the perfect
diagnostic specificity (Figure 7).
Then, we focused on the correlation between MR findings
and clinical disease activity index or biomarkers. Although
MR-score-T showed significant association with CRP
(r = 0.445, p = 0.019) and ESR (r = 0.688, p < 0.01), we
could not find significant association between MR-score-T
and CDAI (r = 0.299, p = 0.146).
Discussion
CD is a chronic inflammatory disorder which may affect
any part of the gastrointestinal tract, frequently involving
the small and large bowel. It is difficult to completely
observe the whole small bowel with conventional endos-
copy and MRI is now increasingly used. DWI has the
capability to detect inflammatory lesion and its utility in
CD activity has been assessed in several studies, while
few papers ever discussed the reason of b value selec-
tion. Oussalah et al. [13] reported the dynamic contrast-
enhanced MRI (DCE-MRI) and DWI with b values 0
and 600 s/mm2. It was also reported that three b values
(0, 100 and 800 s/mm2) could be used with axial images
through the upper and lower abdomen obtained in
Crohn’s disease [15]. Neubauer et al. [16] reported the
utility of DWI in children and young adults suffering
from Crohn’s disease with b values 50 and 800 s/mm2.
Figure 1 Determine the optimal b value in DWI with a learning cohort of patients. The mean CNR and SNR of four b value sequences. The
unit of b value is s/mm2 (A). The ADC values of four b value sequences. The unit of ADC is 10−3 mm2/s (B).
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turned out that 800 s/mm2 was the best choice in this
MRE-DWI examination. Not only the image with b
value 800 s/mm2 had the best SNR and CNR, but it
showed the highest diagnostic sensitivity (74.19%) and
the diagnostic accuracy of it was similar to others.
SBE and DBE can provide high-quality images of the
small intestinal mucosa, which enables the gastroenter-
ologists, receive integral impression and evaluation of
involved small intestine immediately. Due to the lack of
scoring system for enteroscopy, the severity and extent
of lesions in small bowel were assessed by the CECDAI
in the present study. CECDAI can diagnose CD, exclude
normal mucosal breaks, identify damage induced by
nonsteroidal anti-inflammatory drugs, measure disease
activity and severity, assess therapeutic response forclinical trials, and determine medical management for
the patient with small-bowel CD. However, CECDAI is
not suitable for patients with suspicious stenosis or ob-
struction due to the contraindication of capsule endos-
copy (CE).
Some studies had proposed to evaluate disease activity
with scoring systems based on combination of MRI fea-
tures [13,17]. MRE is noninvasive, and the intestinal wall
adjacent to the obstruction could be clearly displayed. In
CD, the MR-score-T has been indicated to correlate with
the endoscopic disease activity, even in colonography
without bowel preparation [13]. In the present study, we
found the similar evidence that both MR-score-S and
MR-score-T were correlated with CECDAI. And bowel
wall enhancement shows the best predictive value for ac-
tive inflammation in our study. The level of bowel wall
Figure 2 Qualitative image quality comparison among four b values. DWI images were obtained from a 30-year-old man. The Inflammatory
lesion of approximal ileum was detected by endoscopy. When b = 800 s/mm2 was adopted, the lesion was demonstrated clearly as well as normal
small intestinal wall, enlarged lymph nodes and abdominal wall structure (A). When b = 1500 s/mm2 was adopted, normal small intestinal wall could
barely be identified (B) and when b = 2000 s/mm2 or b = 2500 s/mm2 was adopted (C and D), even abdominal wall structure became vague. The
enlarged lymph nodes could not be identified when b = 2500 s/mm2 was adopted (D).
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linium is the single, most reliable MRI criterion for dis-
ease activity because that it reflects wall vascularity and
vessel permeability, which increased in active inflammation
[18,19]. Indeed, several studies have proved bowel wall
thickening as an independent predictor of inflammation inFigure 3 Diagnostic effect of different b value groups. In a 28-year-old
b value was 800 s/mm2 (A) or 1500 s/mm2 (B) was chosen. However, when b
signal was apparently depressed and the lesion was missed.CD [13,20]. Interestingly, some MR features as the wall
thickening showed the lower value to assess inflammatory
activity in a few reports [21]. We noticed that without
proper bowel preparation and luminal distension, the wall
thickening caused by constriction sometimes could be
easily confused with inflammatory lesion even after contrastman, high signal intensity in approximal ileum could be detected when
value was 2000 s/mm2 or 2500 s/mm2 (C and D) was selected, the high
Table 2 Diagnostic assessment of active Crohn’s lesions
Reading
protocol
TP FP FN TN Sensitivity Specificity Diagnostic
accuracy
A 42 14 20 24 74.19% 63.16% 66%
B 51 10 11 28 82.26% 73.68% 79%
C 58 4 4 34 93.55% 89.47% 92%
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could appear in chronic inflammation or even normal
bowel wall without properly distention [22]. Sometimes
hyper-enhancement of the mucosa may be the only mani-
festation of active inflammation without any significant
bowel thickening, which can be found in patients with
recurrent CD after fibrotic reaction [23].
In our study, DWI hyper-intensity predicted inflam-
matory activity pretty well, which was closed to bowel
wall enhancement. Fortunately, DWI hyper-intensity has
been found similar possibility on predicting disease ac-
tive in colon [13]. The layer differentiation of DWI
hyper-intensity could be observed in all cases with active
inflammation. MR feature of differentiation between theFigure 4 The combination of MRE and DWI could improve diagnostic sens
CD with multi-segmental lesions in ileum (A, B and E). On LAVA image (A
which was confirmed by enteroscopy (E), While on DWI (B), no abnormal h
A 42-year-old male patient suffered from active CD (C, D and F). On LAVA
detected in distal ileum (C), while on DWI (D), no high signal intensity was
enteroscopy (F).mucosaesubmucosa complex and the muscularis propria
also showed the similar pattern in our study. The
specific mechanism is still to be determined. The inner
layer with higher signal might indicate granulomatous or
fibrotic reaction, and the outer layer with lower signal
might indicate bowel wall edema based on pathologic
findings of CD.
The MaRIA score was recently prospectively validated
and subsequently considered as the benchmark for
assessing inflammatory activity in MRI for ileocolonic
CD [10,24]. Wall thickening, relative contrast enhance-
ment, edema and ulcer were the main parameters while
no DWI factor was included. Rimola J et al. suggested
that the creation of MaRIA-DWI score could be theitivity and specificity. A 34-year-old female patient suffered from active
) abnormal enhancement could be detected in pelvis (white arrow),
igh signal intensity lesion was found in the same cross-sectional slice.
image, suspicious local bowel wall thickening (curved arrow-head) was
found in the same cross-sectional slice, which was confirmed by
Figure 5 The combination of MRE and DWI could improve diagnostic sensitivity and specificity. A thirty-three male patient suffered from active
CD. On LAVA image the jejunum (right upper abdomen) was not distended very well and it was difficult to decide whether it had inflammatory
lesion because of high signal intensity both before (A) and after (B) contrast injection. While on DWI (C), abnormal high signal intensity was found in
the same cross-sectional slice indicating the inflammatory lesion, which was confirmed by enteroscopy.
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score system, ADC value was added as a new parameter.
Unfortunately, the data they got was not compared with
gold standard and the ADC value itself could be variable
according to different b value or MR scanner. So we
adopt the scoring system using by Oussalah et al. and
added other radiological signs in it which we named
“modified MR scoring system”, which we expected could
be more stable and dependable.Figure 6 The correlation between MR score and CECDAI score. Both M
with CECDAI-S (r = 0.717, p < 0.01) and CECDAI-T (r = 0.535, p < 0.01).Although the MR-score-T was correlated with both
ESR and CRP, it did not show significant correlation
with clinical disease activity index in CD. The CDAI
score reflects patients’ general condition including intes-
tinal and parenteral manifestations. It’s a relatively sub-
jective evaluation score depending much more on
patients’ chief complain than clinical, endoscopic or radio-
logic test, which might cause the bias between MR-score-T
and CDAI score. Furthermore, it should be noted that MRIR-score-S and MR-score-T showed a significantly positive correlation
Figure 7 The ROC curve of predicting CD activity. The ROC curve indicated that bowel wall enhancement was the optimal predictor of inflammation
(AUROC=0.87). Besides, DWI hyper-intensity (AUROC=0.83) and bowel wall thickening (AUROC=0.80) could also predict active inflammation pretty well. At
the same time, the layer differentiation of DWI hyper-intensity and differentiation between the mucosaesubmucosa complex and the muscularis propria
presented the perfect diagnostic specificity.
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because of its difficulty in assessing mucosal status. How-
ever, MRI could be adapted as a useful technique for
long-time follow-up.
There were several limitations to this study. First, the
correlation between bowel wall ADCs and other MRI
markers of disease activity were not well investigated at
present. Although ADC of DWI has preliminarily been
demonstrated as an radiological, disease activity marker
in CD [26,27], sometimes endoscopic finding could not
confirm the ADCs findings in the same segments of
inflammatory bowel. Second, in CD, both inflammation
and fibrosis usually coexisted in the same bowel seg-
ments [28,29]. However, it’s still very difficult to identify
whether thickened bowel wall contains substantial fibro-
sis with these imaging sequences.
Conclusions
In conclusion, when DWI was combined with MRE for
CD activity evaluation, b value 800 s/mm2 was recom-
mended as the optimal DWI scanning parameter be-
cause of its good image quality and high diagnostic
sensitivity of lesion detection. When diagnostic accuracy
of active lesion was concerned, it was concluded that the
combination of DWI and MRE showed the highestsensitivity, specificity and diagnostic accuracy compared
with MRE or DWI alone. At the same time, the MR
score obtained from both DWI and MRE radiological
characteristics had showed a significantly positive correl-
ation with CECDAI. Among all the MR score signs,
bowel wall enhancement was the optimal predictor of
active inflammation.
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